Supplementary - Tocilizumab for polyarteritis nodosa
收藏官方服务：
资源简介：
Tocilizumab for polyarteritis nodosa. Supplementary data.
应用场景：
创建时间：
2025-01-01
相关数据集
Additional file 10 of Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges
Additional file 10: Table S10. Brand names and dosage forms of surveyed drugs in China.
NIAID Data Ecosystem60
Canagliflozin impairs T-cell effector function via metabolic suppression in autoimmunity.. Canagliflozin impairs T-cell effector function via metabolic suppression in autoimmunity.
This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual Series
NIAID Data Ecosystem10
Additional file 9 of Evaluating the national system for rare diseases in China from the point of drug access: progress and challenges
Additional file 9: Table S9. Median of hospital-level availability for orphan drugs in each efficacy group.
Figshare2024-02-09 更新10
Table_5_Drug Repositioning for Noonan and LEOPARD Syndromes by Integrating Transcriptomics With a Structure-Based Approach.xlsx
Noonan and LEOPARD syndromes (NS and LS) belong to a group of related disorders called RASopathies characterized by abnormalities of multiple organs and systems including hypertrophic cardiomyopathy a
NIAID Data Ecosystem40
The potential of human regulatory T cells generated ex vivo as a treatment for lupus and other chronic inflammatory diseases
Regulatory T cells prevent autoimmunity by suppressing the reactivity of potentially aggressive self-reactive T cells. Contact-dependent CD4(+) CD25(+) 'professional' suppressor cells and other cytoki
PubMed Central2002-03-12 更新10
